Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 12, 2021

Total Value: $501M (100.0% shares, 0.0% debt)

Holdings (21)

BBIO BridgeBio Pharma Inc. (BBIO) 56.7%

Value $284M Shares 6,068,125 Est. Cost $40.43 Unrealized +32.6%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 6.5%

Value $32.8M Shares 1,472,331 Est. Cost $20.37 Unrealized +40.7%

NUVB Nuvation Bio Inc. (NUVB) 5.0%

Value $25.26M Shares 2,541,009 Est. Cost $11.18 Unrealized -18.9%

HRMY Harmony Biosciences Holdings Inc. (HRMY) 4.5%

Value $22.72M Shares 592,815 Est. Cost $36.46 Unrealized -11.7%

— Elevation Oncology Inc. (ELEV) 4.4%

Value $22.08M Shares 2,834,910 Est. Cost $13.57 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 3.9%

Value $19.59M Shares 1,025,000 Est. Cost $10.24 Unrealized +62.7%

— Aeglea Biotherapeutics Inc. (AGLE) 2.7%

Value $13.45M Shares 1,691,151 Est. Cost $8.00 Unrealized —

ACRS Aclaris Theraputics Inc. (ACRS) 2.3%

Value $11.42M Shares 634,455 Est. Cost $10.31 Unrealized +55.5%

BMEA Biomea Fusion Inc. (BMEA) 1.9%

Value $9.561M Shares 798,757 Est. Cost $17.65 Unrealized -27.9%

— Talaris Therapeutics Inc. (TALS) 1.8%

Value $9.26M Shares 682,923 Est. Cost $14.69 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 1.5%

Value $7.605M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Verona Pharma plc (VRNA) 1.5%

Value $7.302M Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.4%

Value $7.245M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 1.3%

Value $6.601M Shares 886,075 Est. Cost $9.33 Unrealized —

— AVROBIO, Inc. (AVRO) 1.1%

Value $5.635M Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 1.1%

Value $5.311M Shares 3,142,857 Est. Cost $4.35 Unrealized —

— ObsEva SA (OBSV) 0.9%

Value $4.312M Shares 1,386,338 Est. Cost $12.66 Unrealized —

— Atreca Inc. (BCEL) 0.5%

Value $2.415M Shares 387,653 Est. Cost $18.84 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.5%

Value $2.314M Shares 288,571 Est. Cost $11.34 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.4%

Value $1.956M Shares 2,718,226 Est. Cost $2.15 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.0%

Value $227K Shares 191,028 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$284M	56.7%	$40.43	+32.6%	COM	10806X102
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$32.8M	6.5%	$20.37	+40.7%	COM	61225M102
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$25.26M	5.0%	$11.18	-18.9%	COM CL A	67080N101
HRMY	Harmony Biosciences Holdings Inc. (HRMY)	592,815	$22.72M	4.5%	$36.46	-11.7%	COM	413197104
—	Elevation Oncology Inc. (ELEV)	2,834,910	$22.08M	4.4%	$13.57	—	COM	28623U101
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$19.59M	3.9%	$10.24	+62.7%	COM	87164F105
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$13.45M	2.7%	$8.00	—	COM	00773J103
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$11.42M	2.3%	$10.31	+55.5%	COM	00461U105
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$9.561M	1.9%	$17.65	-27.9%	COM	09077A106
—	Talaris Therapeutics Inc. (TALS)	682,923	$9.26M	1.8%	$14.69	—	COM	87410C104
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$7.605M	1.5%	$8.87	—	COM	73730P108
—	Verona Pharma plc (VRNA)	1,332,485	$7.302M	1.5%	$7.38	—	SPONSORED ADS	925050106
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$7.245M	1.4%	$24.31	—	COM	85209E109
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$6.601M	1.3%	$9.33	—	COM	75974E103
—	AVROBIO, Inc. (AVRO)	1,009,779	$5.635M	1.1%	$16.72	—	COM	05455M100
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$5.311M	1.1%	$4.35	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$4.312M	0.9%	$12.66	—	COM	H5861P103
—	Atreca Inc. (BCEL)	387,653	$2.415M	0.5%	$18.84	—	CL A COM	04965G109
—	Viracta Therapeutics Inc. (VIRX)	288,571	$2.314M	0.5%	$11.34	—	COM	92765F108
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$1.956M	0.4%	$2.15	—	COM NEW	98979H202
—	Nabriva Therapeutics plc (NBRV)	191,028	$227K	0.0%	$1.66	—	SHS	G63637113